- Report
- January 2024
- 147 Pages
Global
From €3868EUR$4,250USD£3,316GBP
- Report
- March 2024
- 200 Pages
Global
From €3777EUR$4,150USD£3,238GBP
- Report
- April 2024
- 138 Pages
Global
From €3595EUR$3,950USD£3,082GBP
- Report
- May 2024
- 67 Pages
South Africa
From €2048EUR$2,250USD£1,755GBP
- Report
- August 2023
- 180 Pages
Global
From €3413EUR$3,750USD£2,926GBP
- Report
- January 2025
- 73 Pages
Canada
From €846EUR$930USD£726GBP
- Report
- March 2025
- 44 Pages
United Kingdom
From €828EUR$910USD£710GBP
- Report
- October 2022
- 303 Pages
Global
From €3495EUR$3,840USD£2,996GBP
- Book
- January 2021
- 160 Pages
- Book
- May 2018
- 872 Pages
- Book
- November 2014
- 432 Pages
- Book
- April 2012
- 952 Pages
- Book
- April 2008
- 160 Pages
- Book
- November 2003
- 736 Pages
- Book
- April 2025
- 1024 Pages
€1575EUR$1,854USD£1,397GBP

The Dementia market within the context of Diagnostics is a rapidly growing field of medical research and development. It is focused on the diagnosis and treatment of dementia, a progressive neurological disorder that affects memory, thinking, behavior, and emotion. Diagnostic tests are used to identify the presence of dementia and to differentiate between different types of dementia. These tests can include cognitive tests, imaging tests, and laboratory tests.
The Dementia market is driven by the increasing prevalence of dementia, as well as the need for more accurate and timely diagnosis. The development of new technologies and treatments is also driving the market.
Companies in the Dementia market include Roche, Abbott, Siemens, GE Healthcare, Philips, and Hologic. These companies are involved in the development and manufacture of diagnostic tests, imaging systems, and treatments for dementia. Show Less Read more